Sociodemographic Disparities in Hepatitis B Treatment: A Real-World Analysis of 3 Safety-Net Health Systems in the United States
Among an ethnically diverse multicenter safety-net cohort of CHB patients, less than one-third of treatment-eligible patients received antiviral treatment. Significant disparities in CHB treatment were observed by sociodemographic characteristics.
Authors
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- George Therapondos (ORCID: https://orcid.org/0000-0002-6113-4972)
- Onkar Kshirsagar (ORCID: https://orcid.org/0000-0003-2141-8716)
- Mae Thamer (ORCID: https://orcid.org/0000-0002-7559-7193)
- Mamta K. Jain (ORCID: https://orcid.org/0000-0003-2292-6544)
- Bolin Niu
Institutions
- Parkland Health & Hospital System (US)
- MetroHealth (US)
- Ochsner Health System (US)
- VA Palo Alto Health Care System (US)
- Medical Technology and Practice Patterns Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae571
- Citations
- 5
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Gilead Sciences